Aijaz

Hospitals' CapEx Cautions May Be Limiting Intuitive Surgical Growth, For Now

Thanks for the response, but I'm really surprised by what you've written.

Management has always informed investors of seasonality in their earnings. Q4 is the strongest quarter in the year. Q1 is typically weaker than the prior year's Q4 for system sales.
Guidance was raised to 42% sales growth for system sales. It's also meaningful to note that this "small" increase in system sales growth was on top of increased guidance the previous quarter. I'd recommend you listen to the past couple of conference calls to get the facts straight.